163 related articles for article (PubMed ID: 19289711)
41. Effects of mobile phone WeChat services improve adherence to corticosteroid nasal spray treatment for chronic rhinosinusitis after functional endoscopic sinus surgery: a 3-month follow-up study.
Feng S; Liang Z; Zhang R; Liao W; Chen Y; Fan Y; Li H
Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1477-1485. PubMed ID: 27822702
[TBL] [Abstract][Full Text] [Related]
42. Validation of the Sino-Nasal Outcome Test 20 (SNOT-20) domains in nonsurgical patients.
Pynnonen MA; Kim HM; Terrell JE
Am J Rhinol Allergy; 2009; 23(1):40-5. PubMed ID: 19379611
[TBL] [Abstract][Full Text] [Related]
43. Topical budesonide via mucosal atomization device in refractory postoperative chronic rhinosinusitis.
Kanowitz SJ; Batra PS; Citardi MJ
Otolaryngol Head Neck Surg; 2008 Jul; 139(1):131-6. PubMed ID: 18585575
[TBL] [Abstract][Full Text] [Related]
44. Antibiotics in eosinophilic chronic rhinosinusitis: Rethinking maximal antimicrobial medical therapy.
Günel C; Bleier BS; Meteoglu I
Laryngoscope; 2017 Apr; 127(4):794-796. PubMed ID: 27888519
[TBL] [Abstract][Full Text] [Related]
45. Effects of intranasal steroid spray in bacterial culture of chronic rhinosinusitis.
Ho CY; Chan KT
Am J Rhinol Allergy; 2009; 23(4):405-8. PubMed ID: 19671256
[TBL] [Abstract][Full Text] [Related]
46. Budesonide nasal irrigation improved Lund-Kennedy endoscopic score of chronic rhinosinusitis patients after endoscopic sinus surgery.
Huang ZZ; Chen XZ; Huang JC; Wang ZY; Li X; Chen XH; Lai XP; Chang LH; Zhang GH
Eur Arch Otorhinolaryngol; 2019 May; 276(5):1397-1403. PubMed ID: 30788581
[TBL] [Abstract][Full Text] [Related]
47. Reversible nasal airway obstruction: does change in nasal peak inspiratory flow following decongestion predict response to topical steroids in chronic rhinosinusitis patients?
Koo Ng NK; Young D; McGarry GW
J Laryngol Otol; 2012 Dec; 126(12):1238-40. PubMed ID: 23057871
[TBL] [Abstract][Full Text] [Related]
48. Effect of budesonide aqueous nasal spray on hypothalamic-pituitary-adrenal axis function in children with allergic rhinitis.
Kim KT; Rabinovitch N; Uryniak T; Simpson B; O'Dowd L; Casty F
Ann Allergy Asthma Immunol; 2004 Jul; 93(1):61-7. PubMed ID: 15281473
[TBL] [Abstract][Full Text] [Related]
49. Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial.
Dolor RJ; Witsell DL; Hellkamp AS; Williams JW; Califf RM; Simel DL;
JAMA; 2001 Dec; 286(24):3097-105. PubMed ID: 11754675
[TBL] [Abstract][Full Text] [Related]
50. Nasal nebulization inhalation of budesonide for chronic rhinosinusitis with nasal polyps: A protocol for systematic review and meta-analysis.
Zheng PJ; Zhang YY; Zhang SH; Liu GF; Wang JS
Medicine (Baltimore); 2020 May; 99(22):e20354. PubMed ID: 32481416
[TBL] [Abstract][Full Text] [Related]
51. Quantification of Budesonide Retained in the Sinonasal Cavity After High-Volume Saline Irrigation in Post-Operative Chronic Rhinosinusitis.
Shipman PA; Yathavan B; Gill AS; Pollard CE; Yellepeddi V; Ghandehari H; Alt JA; Pulsipher A; Smith KA
Am J Rhinol Allergy; 2024 May; 38(3):169-177. PubMed ID: 38456692
[TBL] [Abstract][Full Text] [Related]
52. Evaluating metrics of responsiveness using patient-reported outcome measures in chronic rhinosinusitis.
Lidder AK; Detwiller KY; Price CP; Kern RC; Conley DB; Shintani-Smith S; Welch KC; Chandra RK; Peters AT; Grammer LC; Man LX; Schleimer RP; Tan BK
Int Forum Allergy Rhinol; 2017 Feb; 7(2):128-134. PubMed ID: 28177596
[TBL] [Abstract][Full Text] [Related]
53. Effectiveness of leukotriene receptor antagonism in the postoperative management of chronic rhinosinusitis.
Yelverton JC; Holmes TW; Johnson CM; Gelves CR; Kountakis SE
Int Forum Allergy Rhinol; 2016 Mar; 6(3):243-7. PubMed ID: 26834076
[TBL] [Abstract][Full Text] [Related]
54. A pilot study of the effects of intranasal budesonide delivered by NasoNeb® on patients with perennial allergic rhinitis.
Brown K; Lane J; Silva MP; DeTineo M; Naclerio RM; Baroody FM
Int Forum Allergy Rhinol; 2014 Jan; 4(1):43-8. PubMed ID: 24574125
[TBL] [Abstract][Full Text] [Related]
55. The effectiveness of topical colloidal silver in recalcitrant chronic rhinosinusitis: a randomized crossover control trial.
Scott JR; Krishnan R; Rotenberg BW; Sowerby LJ
J Otolaryngol Head Neck Surg; 2017 Nov; 46(1):64. PubMed ID: 29178954
[TBL] [Abstract][Full Text] [Related]
56. Lack of long-term add-on effect by montelukast in postoperative chronic rhinosinusitis patients with nasal polyps.
Van Gerven L; Langdon C; Cordero A; Cardelús S; Mullol J; Alobid I
Laryngoscope; 2018 Aug; 128(8):1743-1751. PubMed ID: 29114894
[TBL] [Abstract][Full Text] [Related]
57. Amoxicillin-clavulanate for patients with acute exacerbation of chronic rhinosinusitis: a prospective, double-blinded, placebo-controlled trial.
Sabino HA; Valera FC; Aragon DC; Fantucci MZ; Titoneli CC; Martinez R; Anselmo-Lima WT; Tamashiro E
Int Forum Allergy Rhinol; 2017 Feb; 7(2):135-142. PubMed ID: 27610609
[TBL] [Abstract][Full Text] [Related]
58. [The efficacy of sinuforte in the starting monotherapy of the patients presenting with acute rhinosinusitis].
Semenov VF; Banashek-Meshcheriakova TV
Vestn Otorinolaringol; 2011; (3):68-70. PubMed ID: 21720299
[TBL] [Abstract][Full Text] [Related]
59. [The efficacy and safety of a short course of budesonide inhalation suspension via transnasal nebulization in chronic rhinosinusitis with nasal polyps].
Wang C; Lou H; Lou W; Zhang L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 26(8):347-50. PubMed ID: 22730816
[TBL] [Abstract][Full Text] [Related]
60. Treatment Outcomes in Chronic Rhinosinusitis Refractory to Maximal Medical Therapy: A Prospective Observational Study Under Real-World Conditions.
Dejaco D; Riedl D; Giotakis A; Bektic-Tadic L; Kahler P; Riechelmann H
Ear Nose Throat J; 2021 Feb; 100(2):NP77-NP86. PubMed ID: 31266398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
